innospec inc. - IOSP

IOSP

Close Chg Chg %
80.65 0.00 0.00%

Closed Market

80.65

0.00 (0.00%)

Volume: 120.33K

Last Updated:

Jun 5, 2026, 3:59 PM EDT

Company Overview: innospec inc. - IOSP

IOSP Key Data

Open

$80.60

Day Range

80.07 - 82.09

52 Week Range

65.58 - 92.14

Market Cap

$1.99B

Shares Outstanding

24.63M

Public Float

24.23M

Beta

0.90

Rev. Per Employee

N/A

P/E Ratio

17.58

EPS

$4.60

Yield

221.95%

Dividend

$0.92

EX-DIVIDEND DATE

May 19, 2026

SHORT INTEREST

N/A

AVERAGE VOLUME

230.85K

 

IOSP Performance

1 Week
 
-2.72%
 
1 Month
 
0.16%
 
3 Months
 
11.88%
 
1 Year
 
-6.33%
 
5 Years
 
-20.81%
 

IOSP Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings 3
Full Ratings ➔

About innospec inc. - IOSP

Innospec, Inc. engages in the development, manufacture, blend, marketing, and supply of fuel additives, oilfield chemicals, personal care, and other specialty chemicals. It operates through the following segments: Fuel Specialties, Performance Chemicals, and Oilfield Services. The Fuel Specialties segment develops, manufactures, blends, markets, and supplies a range of specialty chemical products used as additives to a range of fuels. The Performance Chemicals segment provides technology-based solutions for customers processes or products focused on the personal care, home care, agrochemical, and mining industries. The Oilfield Services segment refers to the development and marketing of chemical solutions for fracturing, drilling, stimulation, completion operations, products for oil and gas production, and transport. The company was founded in 1938 and is headquartered in Englewood, CO.

IOSP At a Glance

Innospec, Inc.
8310 South Valley Highway
Englewood, Colorado 80112
Phone 1-303-792-5554 Revenue 1.78B
Industry Chemicals: Major Diversified Net Income 116.60M
Sector Process Industries Employees 2,450
Fiscal Year-end 12 / 2026
View SEC Filings

IOSP Valuation

P/E Current 17.577
P/E Ratio (with extraordinary items) N/A
P/E Ratio (without extraordinary items) 16.406
Price to Sales Ratio 1.076
Price to Book Ratio 1.43
Price to Cash Flow Ratio 13.83
Enterprise Value to EBITDA 8.171
Enterprise Value to Sales 0.945
Total Debt to Enterprise Value 0.031

IOSP Efficiency

Revenue/Employee 725,714.286
Income Per Employee 47,591.837
Receivables Turnover 5.194
Total Asset Turnover 0.997

IOSP Liquidity

Current Ratio 2.79
Quick Ratio 1.875
Cash Ratio 0.812

IOSP Profitability

Gross Margin 27.137
Operating Margin 8.791
Pretax Margin 7.767
Net Margin 6.558
Return on Assets 6.538
Return on Equity 9.191
Return on Total Capital 8.457
Return on Invested Capital 8.952

IOSP Capital Structure

Total Debt to Total Equity 3.974
Total Debt to Total Capital 3.822
Total Debt to Total Assets 2.876
Long-Term Debt to Equity 2.775
Long-Term Debt to Total Capital 2.669
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Innospec Inc. - IOSP

Collapse All in section
All values USD millions. 2022 2023 2024 2025 5-year trend
Sales/Revenue
1.96B 1.95B 1.85B 1.78B
Sales Growth
+32.38% -0.76% -5.31% -3.65%
Cost of Goods Sold (COGS) incl D&A
1.39B 1.37B 1.31B 1.30B
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
45.00M 47.40M 48.30M 49.30M
Depreciation
31.00M 36.80M 35.70M 37.70M
Amortization of Intangibles
14.00M 10.60M 12.60M 11.60M
COGS Growth
+30.74% -1.63% -3.89% -1.32%
Gross Income
575.00M 582.80M 532.60M 482.50M
Gross Income Growth
+36.51% +1.36% -8.61% -9.41%
Gross Profit Margin
+29.28% +29.91% +28.86% +27.14%
2022 2023 2024 2025 5-year trend
SG&A Expense
387.70M 418.10M 351.50M 326.20M
Research & Development
38.70M 41.70M 47.80M 51.00M
Other SG&A
349.00M 376.40M 303.70M 275.20M
SGA Growth
+33.28% +7.84% -15.93% -7.20%
Other Operating Expense
- - - -
-
Unusual Expense
(700.00K) 7.10M 153.70M 30.10M
EBIT after Unusual Expense
188.00M 157.60M 27.40M 126.20M
Non Operating Income/Expense
(2.30M) 16.80M 13.80M 11.90M
Non-Operating Interest Income
- 2.30M 9.30M 9.20M
Equity in Earnings of Affiliates
- - - -
-
Interest Expense
- - - 1.10M
-
Interest Expense Growth
- - - -26.67%
-
Gross Interest Expense
- - - 1.10M
-
Interest Capitalized
- - - -
-
Pretax Income
184.60M 174.40M 41.20M 138.10M
Pretax Income Growth
+37.35% -5.53% -76.38% +235.19%
Pretax Margin
+9.40% +8.95% +2.23% +7.77%
Income Tax
51.60M 35.30M 5.60M 21.50M
Income Tax - Current - Domestic
33.50M 12.60M 19.80M 6.20M
Income Tax - Current - Foreign
23.10M 18.60M 26.20M 24.30M
Income Tax - Deferred - Domestic
(4.40M) 5.50M (4.60M) (8.00M)
Income Tax - Deferred - Foreign
(600.00K) (1.40M) (35.80M) (1.00M)
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Other After Tax Income (Expense)
- - - -
-
Consolidated Net Income
133.00M 139.10M 35.60M 116.60M
Minority Interest Expense
- - - -
-
Net Income
133.00M 139.10M 35.60M 116.60M
Net Income Growth
+42.86% +4.59% -74.41% +227.53%
Net Margin Growth
+6.77% +7.14% +1.93% +6.56%
Extraordinaries & Discontinued Operations
- - - -
-
Discontinued Operations
- - - -
-
Net Income After Extraordinaries
133.00M 139.10M 35.60M 116.60M
Preferred Dividends
- - - -
-
Net Income Available to Common
133.00M 139.10M 35.60M 116.60M
EPS (Basic)
5.3657 5.5974 1.4279 4.6865
EPS (Basic) Growth
+42.05% +4.32% -74.49% +228.21%
Basic Shares Outstanding
24.79M 24.85M 24.93M 24.88M
EPS (Diluted)
5.3238 5.5591 1.4172 4.6653
EPS (Diluted) Growth
+42.12% +4.42% -74.51% +229.19%
Diluted Shares Outstanding
24.98M 25.02M 25.12M 24.99M
EBITDA
232.30M 212.10M 229.40M 205.60M
EBITDA Growth
+31.61% -8.70% +8.16% -10.37%
EBITDA Margin
+11.83% +10.88% +12.43% +11.56%

Snapshot

Average Recommendation BUY Average Target Price 99.333
Number of Ratings 3 Current Quarters Estimate 1.05
FY Report Date 06 / 2026 Current Year's Estimate 4.83
Last Quarter’s Earnings 1.05 Median PE on CY Estimate N/A
Year Ago Earnings 5.27 Next Fiscal Year Estimate 6.11
Median PE on Next FY Estimate N/A

Earnings Per Share

This Quarter Next Quarter This Fiscal Next Fiscal
# of Estimates 2 2 3 2
Mean Estimate 1.05 1.24 4.83 6.11
High Estimates 1.06 1.26 4.90 6.17
Low Estimate 1.04 1.21 4.74 6.05
Coefficient of Variance 1.35 2.86 1.69 1.39

Analysts Recommendations

Current 1 Month Ago 3 Months Ago
BUY 3 3 3
OVERWEIGHT 0 0 0
HOLD 0 0 0
UNDERWEIGHT 0 0 0
SELL 0 0 0
MEAN Buy Buy Buy

Insider Actions for Innospec Inc. - IOSP

Date Name Shares Transaction Value
Feb 20, 2026 Ian Philip Cleminson EVP & CFO 18,238 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Feb 20, 2026 Corbin Barnes SVP, Corporate Dev and IR 10,765 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Feb 20, 2026 Trey Griffin SVP, HUMAN RESOURCES 8,041 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00

Innospec Inc. in the News